Edap TMS SA (EDAP)
2.52
-0.11
(-4.18%)
USD |
NASDAQ |
Nov 14, 16:00
2.52
0.00 (0.00%)
After-Hours: 20:00
Edap TMS Gross Profit (Annual): 26.43M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.43M |
| December 31, 2022 | 25.51M |
| December 31, 2021 | 21.80M |
| December 31, 2020 | 20.99M |
| December 31, 2019 | 23.51M |
| December 31, 2018 | 19.98M |
| December 31, 2017 | 16.77M |
| December 31, 2016 | 18.16M |
| December 31, 2015 | 15.30M |
| December 31, 2014 | 14.90M |
| December 31, 2013 | 12.38M |
| December 31, 2012 | 13.41M |
| December 31, 2011 | 12.35M |
| December 31, 2010 | 12.53M |
| Date | Value |
|---|---|
| December 31, 2009 | 14.88M |
| December 31, 2008 | 13.36M |
| December 31, 2007 | 12.58M |
| December 31, 2006 | 10.45M |
| December 31, 2005 | 10.57M |
| December 31, 2004 | 10.55M |
| December 31, 2003 | 6.079M |
| December 31, 2002 | 8.007M |
| December 31, 2001 | 7.874M |
| December 31, 2000 | 12.10M |
| December 31, 1999 | 8.933M |
| December 31, 1998 | 13.00M |
| December 31, 1997 | 18.73M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
20.99M
Minimum
2020
26.43M
Maximum
2023
23.65M
Average
23.51M
Median
2019
Gross Profit (Annual) Benchmarks
| Genfit SA | 30.56M |
| Cellectis SA | 0.018M |
| Adaptimmune Therapeutics PLC | -- |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | -4.587M |